Key Takeaways
- HPV causes 99.7% of cervical cancers — an HPV test detects the virus years before cell changes appear, making it significantly more sensitive than a Pap smear alone
- HPV test combined with Pap smear starts from AED 299 at DCDC Dubai Healthcare City; standalone HPV DNA testing ranges from AED 300-600 across Dubai clinics
- Women aged 30-65 should have HPV co-testing every 5 years according to ACOG — women 25-29 can opt for HPV primary screening every 5 years
- Gardasil 9 vaccine protects against 9 HPV strains responsible for 90% of HPV-related cancers; cost ranges from AED 500-1,200 per dose in Dubai
- A positive HPV result does NOT mean cancer — approximately 90% of HPV infections clear naturally within 2 years without treatment
- HPV types 16 and 18 cause 70% of cervical cancers; genotyping identifies exact strains to guide management decisions
- Men benefit from HPV vaccination too — HPV causes oropharyngeal, anal, and penile cancers in males
- DCDC offers same-week HPV screening with female gynecologists, results in 5-7 working days, and direct insurance billing with 20+ providers
An HPV test is the single most effective screening tool for preventing cervical cancer in Dubai. Human Papillomavirus (HPV) is the world's most common sexually transmitted infection — approximately 80% of sexually active adults will contract at least one strain during their lifetime. While most infections resolve spontaneously, persistent high-risk HPV causes virtually all cervical cancers, killing over 340,000 women globally each year. At DCDC Dubai Healthcare City, HPV co-testing with Pap smear starts from AED 299 and provides results within 5-7 working days — early detection that can prevent cancer before it ever develops.
Despite being almost entirely preventable through screening and vaccination, cervical cancer remains a concern in the UAE due to low screening uptake. The key is identifying high-risk HPV infections before they progress to precancerous changes — and that starts with understanding when, why, and how to get an HPV test. Whether you are scheduling your first screening, following up on an abnormal result, considering the HPV vaccine, or simply want to understand your options, this evidence-based guide covers everything Dubai residents need to know about HPV testing in 2026.
Health Screening Packages
Save with our bundled screening packages — specialist consultation included
What Is an HPV Test and How Does It Work?
An HPV test is a laboratory analysis that detects the presence of high-risk Human Papillomavirus DNA or RNA in cells collected from the cervix. Unlike a Pap smear, which identifies abnormal cell changes that have already occurred, the HPV test detects the virus itself — often years before any cellular abnormalities become visible under a microscope. This makes HPV testing the most sensitive screening tool available for predicting cervical cancer risk.
There are over 200 types of HPV, but only about 14 are classified as high-risk for causing cancer. Among these, HPV types 16 and 18 are the most dangerous, responsible for approximately 70% of all cervical cancer cases worldwide. The remaining high-risk types — including 31, 33, 45, 52, and 58 — account for an additional 20% of cases. Low-risk HPV types (such as 6 and 11) cause genital warts but are not associated with cancer.
The sample collection process is virtually identical to a Pap smear — a small soft brush collects cells from the cervix during a brief pelvic examination lasting under 60 seconds. The sample is then sent for laboratory analysis using one of several testing methodologies. The World Health Organization and the American College of Obstetricians and Gynecologists (ACOG) both recommend HPV testing as a primary screening method for women aged 30 and over, either alone or as a co-test alongside the Pap smear.
Types of HPV Tests Available in Dubai
Several different HPV testing methodologies are available in Dubai, each providing different levels of information about your infection status. Understanding the differences helps you and your gynecologist select the most appropriate test for your clinical situation.
HPV DNA Test (Most Common)
The HPV DNA test detects the genetic material of high-risk HPV types in cervical cells. It screens for a panel of 14 high-risk strains and reports a pooled result — positive or negative for high-risk HPV overall. Advanced versions (such as the cobas HPV test) also specifically identify HPV 16 and HPV 18 separately, as these carry the highest cancer progression risk. The Hybrid Capture 2 (HC2) assay is another widely used platform. A positive result confirms high-risk HPV is present but does not indicate whether the infection is new, persistent, or actively causing changes.
HPV Genotyping (Full Panel)
HPV genotyping identifies the specific strain(s) present — for example, HPV 16, HPV 31, or HPV 52. This is clinically valuable because cancer risk varies significantly between strains. HPV 16 has the highest progression risk, followed by HPV 18. Knowing the exact strain helps your gynecologist determine surveillance intervals. Genotyping is particularly useful for women with persistent infections, those being monitored after CIN treatment, or when co-testing shows HPV positive with normal cytology.
HPV mRNA Test (Newest Generation)
The HPV mRNA test detects E6 and E7 oncogene expression — biological markers indicating the virus is actively driving cell transformation toward cancer. This distinction matters: many HPV infections are transient and will clear without harm. The mRNA test identifies infections more likely to progress, reducing unnecessary colposcopies triggered by transient HPV DNA positivity. The Aptima HPV test is the most widely used mRNA-based platform. While not as widely available as DNA testing in Dubai, it is offered at select diagnostic centres.
HPV Co-Testing (Pap Smear + HPV Test)
Co-testing combines a Pap smear and HPV test on the same cervical sample, collected during a single appointment. This is the gold standard for cervical cancer screening in women aged 30-65. The Pap detects existing cell changes while the HPV test identifies women carrying the virus who may develop changes in the future. Together, co-testing catches over 99% of significant cervical abnormalities. A double-negative co-test means your cervical cancer risk for the next 5 years approaches zero.
HPV Test Dubai Cost: Full Pricing Breakdown
The cost of HPV testing in Dubai varies by test type, facility, and whether it is combined with a Pap smear. At DCDC, HPV co-testing with Pap smear starts from AED 299 — positioned as one of the most accessible options in Dubai Healthcare City. Below is a comprehensive pricing guide.
| Test Type | DCDC / Dubai Price Range (AED) | What It Includes |
|---|---|---|
| HPV + Pap smear co-test | From AED 299 | High-risk HPV panel + cervical cytology in one sample |
| HPV DNA test (standalone) | AED 300–600 | 14-type high-risk HPV panel; some specify HPV 16/18 |
| HPV genotyping (full panel) | AED 400–800 | Individual strain identification for all 14 high-risk types |
| HPV mRNA test (Aptima) | AED 500–900 | Oncogene expression testing — active infection indicator |
| Gardasil 9 vaccine (per dose) | AED 500–1,200 | 9-valent HPV vaccine; 2 or 3 doses depending on age |
| Colposcopy (if needed) | AED 800–1,500 | Magnified cervical examination + possible biopsy |
| LEEP procedure (if CIN2/3) | AED 2,000–4,000 | Excision of precancerous tissue under local anaesthesia |
HPV test pricing in Dubai (2026). Most comprehensive insurance plans cover HPV screening as preventive care. DCDC offers direct billing with 20+ insurers including Daman, AXA, and Bupa.
Most comprehensive health insurance plans in the UAE cover HPV testing as preventive cervical screening when requested by a gynecologist. The DHA Essential Benefits Plan mandates preventive screening coverage, and most employer-sponsored plans include cervical screening benefits. For self-pay patients, package pricing for Pap + HPV co-testing is typically more cost-effective than ordering each test separately. At DCDC, direct insurance billing eliminates out-of-pocket payment at the time of service for covered patients.
Who Needs an HPV Test? Screening Guidelines by Age
HPV testing recommendations depend on age, screening history, and individual risk factors. The following guidelines reflect the most current recommendations from ACOG, the American Cancer Society (ACS), and the U.S. Preventive Services Task Force (USPSTF) as of 2026.
| Age Group | Recommended Screening | Frequency | Notes |
|---|---|---|---|
| Under 21 | No cervical screening | N/A | Regardless of sexual activity; risk of overtreatment |
| 21–24 | Pap smear only | Every 3 years | HPV test only if Pap abnormal (reflex testing) |
| 25–29 | Pap alone OR HPV primary | 3 years (Pap) / 5 years (HPV) | ACS 2023 guidelines prefer HPV primary from age 25 |
| 30–65 | Pap + HPV co-test OR HPV primary | Every 5 years | Gold standard; longest safe interval when both negative |
| Over 65 | May discontinue | Per gynecologist | If adequate prior screening with no CIN2+ history |
Based on ACOG, ACS, and USPSTF guidelines (2023-2026). Individual risk factors may warrant more frequent screening.
Certain women require more frequent HPV testing regardless of age: those living with HIV, organ transplant recipients on immunosuppressive therapy, women with a history of CIN2 or CIN3, those exposed to diethylstilbestrol (DES) in utero, and women who have never been screened or have gaps exceeding 5 years. If you fall into any of these categories, consult your gynecologist about a personalized schedule. For a comprehensive overview of all recommended cervical screening, read our guide to cervical cancer screening in Dubai.
Book Your HPV Screening at DCDC
Same-week appointments available with female gynecologists. HPV co-testing from AED 299 with results in 5-7 working days.
Call or WhatsApp to schedule
HPV Test vs Pap Smear: Which Do You Need?
One of the most common questions women ask is whether they need an HPV test, a Pap smear, or both. While both are cervical screening tools, they measure fundamentally different things and serve complementary purposes.
| Feature | HPV Test | Pap Smear |
|---|---|---|
| What it detects | Presence of high-risk HPV virus (DNA/RNA) | Abnormal cervical cell changes (cytology) |
| Sensitivity for CIN2+ | 95–97% | 55–65% |
| Specificity | Moderate (detects transient infections too) | High (detects actual cell changes) |
| Positive result means | High-risk HPV present (may/may not have cell changes) | Abnormal cells found (may/may not involve HPV) |
| Best for | Predicting future cervical cancer risk | Detecting existing precancerous changes |
| Screening interval if negative | 5 years | 3 years |
| Misses cancers (false negative rate) | 3–5% | 35–45% |
The HPV test is more sensitive (catches more disease), while the Pap is more specific (fewer false alarms). Together as a co-test they catch over 99% of cervical abnormalities.
Research published in The Lancet demonstrates that HPV-based screening reduces the incidence of invasive cervical cancer by 60-70% compared to Pap smear screening alone. This evidence underpins the global shift toward HPV primary screening. However, the ideal approach for most women aged 30-65 remains co-testing — combining both tests to leverage the HPV test's sensitivity and the Pap smear's specificity for maximum protection.
What to Expect at DCDC: Your HPV Test Appointment
At DCDC Dubai Healthcare City, HPV screening follows a streamlined patient journey designed for comfort, privacy, and efficiency. Here is exactly what happens from arrival to results.
Before Your Test: How to Prepare
- Schedule mid-cycle: Avoid booking during your menstrual period. Ideal timing is 10-20 days after the first day of your last period
- Avoid vaginal products: No vaginal creams, douches, lubricants, or suppositories for 48 hours before testing
- Avoid intercourse: Refrain from sexual intercourse for 24-48 hours before your appointment
- Pre-medication (optional): Take ibuprofen or paracetamol 30 minutes beforehand if you experience discomfort during pelvic exams
- Bring insurance card: DCDC handles pre-authorization on-site for covered patients
Arrival and Check-In at DCDC
DCDC is located in Building 64, Block A, Al Razi Medical Complex in Dubai Healthcare City — with free dedicated on-site parking. Check-in takes approximately 5 minutes. If you have insurance, the reception team verifies coverage and handles pre-authorization immediately. Average wait time at DCDC is just 15 minutes. You will be seen by a female gynecologist if preferred — available upon request at time of booking.
The Procedure: Quick and Simple
You lie on an examination table in a comfortable position. The gynecologist gently inserts a speculum to visualize the cervix, then uses a small soft brush to collect cells from the cervical surface and canal. This collection takes approximately 30 seconds. The same sample is used for both Pap smear and HPV testing when co-testing is ordered. The entire appointment — including undressing and dressing — takes less than 10 minutes. Most women describe mild pressure but not pain.
Results and Follow-Up
HPV test results are available within 5-7 working days. Your gynecologist reviews the results and contacts you to discuss findings. If both HPV and Pap are negative, you receive reassurance and a reminder for your next screening in 5 years. If follow-up is needed — such as colposcopy for a positive HPV 16/18 result — it is scheduled promptly at the same facility. Results are accessible through the DCDC patient portal for your records.
Understanding Your HPV Test Results
Receiving HPV test results can be anxiety-provoking, particularly if positive. Understanding what each result means — and what it does NOT mean — helps you feel informed and in control of your health decisions.
HPV Negative Result
A negative HPV test means no high-risk HPV strains were detected. Combined with a normal Pap smear, this provides the strongest possible reassurance — your risk of developing cervical cancer within the next 5 years approaches zero. Return for routine screening in 5 years (co-test) or as advised by your gynecologist.
HPV Positive, Normal Pap Smear
This is common and often causes unnecessary alarm. It means high-risk HPV is present but has not caused visible cell changes. In approximately 90% of cases, the immune system clears the infection within 1-2 years. Management depends on the strain: if HPV 16 or 18 is identified, colposcopy is recommended immediately. For other high-risk types, repeat co-testing in 12 months is standard. If HPV persists at follow-up, colposcopy is then performed.
HPV Positive, Abnormal Pap Smear
When both tests are abnormal, colposcopy is recommended. This is NOT a cancer diagnosis — it means closer examination is needed. During colposcopy, a magnifying instrument examines the cervix in detail and a biopsy (small tissue sample) may be taken from suspicious areas. Biopsy results determine whether precancerous changes (CIN1, CIN2, or CIN3) are present. Most precancerous changes detected and treated early have a cure rate approaching 100%. For more on what follows, see our Pap smear test guide.
Understanding CIN Grades
| CIN Grade | Severity | Meaning | Typical Management |
|---|---|---|---|
| CIN 1 | Mild dysplasia | Minor cell changes, usually HPV-driven; often regresses spontaneously | Observation + repeat testing in 12 months |
| CIN 2 | Moderate dysplasia | More significant changes; may regress or progress | Treatment (LEEP/cryotherapy) or observation in young women |
| CIN 3 | Severe dysplasia | High-grade changes likely to progress if untreated | Treatment required (LEEP, cone biopsy, or laser ablation) |
CIN is NOT cancer. It refers to precancerous changes that can take 10-20 years to progress to invasive cancer if left untreated. Early detection and treatment prevent progression in virtually all cases.
HPV Vaccine Dubai: Gardasil 9 Prevention Guide
While HPV testing detects existing infections, the HPV vaccine prevents infection from occurring in the first place. Vaccination and screening are complementary strategies — one does not replace the other. According to Dr. Parisa Dini, "I recommend the Gardasil 9 vaccine to all eligible patients regardless of age because even women who have been exposed to one or two HPV types benefit from protection against the remaining strains they haven't encountered. Prevention and screening together give us the best chance of eliminating cervical cancer."
Gardasil 9: What It Covers
The Gardasil 9 vaccine protects against 9 HPV types: 6, 11, 16, 18, 31, 33, 45, 52, and 58. This includes two low-risk types causing 90% of genital warts (types 6 and 11) and seven high-risk types responsible for approximately 90% of HPV-related cancers. Clinical trials demonstrate near 100% efficacy in preventing cervical, vaginal, vulvar, and anal precancers caused by targeted strains when administered before HPV exposure.
HPV Vaccine Schedule and Dosing
| Age at First Dose | Number of Doses | Schedule | Cost per Dose (AED) |
|---|---|---|---|
| 9–14 years | 2 doses | 0 and 6-12 months apart | AED 500–1,200 |
| 15–26 years | 3 doses | 0, 2, and 6 months | AED 500–1,200 |
| 27–45 years | 3 doses | 0, 2, and 6 months (shared decision) | AED 500–1,200 |
Gardasil 9 vaccination schedule (2026). Ages 9-14 require only 2 doses due to stronger immune response. The vaccine is available at DCDC for all eligible ages.
The ideal age for vaccination is 9-14 years, before any potential HPV exposure. However, the vaccine remains beneficial for adults up to age 45 who have not been exposed to all 9 targeted strains. Even sexually active adults typically benefit because most people have not been exposed to all vaccine-covered types. Vaccinated women still need regular screening because the vaccine does not cover all cancer-causing HPV types and does not treat existing infections.
HPV and Cervical Cancer Risk in the UAE
Cervical cancer is the fourth most common cancer in women aged 15-44 in the UAE according to the International Agency for Research on Cancer (IARC). The age-standardized incidence rate is approximately 5.7 per 100,000 women. While lower than the global average, this still represents a meaningful burden of entirely preventable disease.
The primary factor driving cervical cancer cases in the UAE is low screening uptake. Cultural barriers, lack of awareness about HPV, and the misconception that screening is only necessary after symptoms appear all contribute to delayed diagnosis. The statistics are stark: when cervical cancer is diagnosed at an early stage, the 5-year survival rate exceeds 92%. When diagnosed late, survival drops to approximately 17%. The difference is screening.
The WHO Global Strategy to Eliminate Cervical Cancer targets 90% HPV vaccination coverage, 70% screening coverage with high-performance tests by ages 35 and 45, and 90% treatment of precancerous lesions. The UAE has made progress through school-based vaccination programs, but screening rates remain below optimal levels. A single HPV test can identify women at risk years before cancer develops. For related women's health screening information, read our guide to women's health screening in Dubai.
Protect Yourself: HPV Test + Vaccine at DCDC
Comprehensive HPV screening and Gardasil 9 vaccination available at DCDC Dubai Healthcare City. Female gynecologists, direct insurance billing, same-week appointments.
Call +971 4 243 1113 or WhatsApp
How Often Should You Get an HPV Test?
Screening frequency depends on your age, test type, and individual risk profile. The following evidence-based guidelines help you understand the appropriate interval for your situation.
- Pap + HPV co-testing (ages 30-65): Every 5 years if both negative — the most widely recommended approach providing the longest safe screening interval
- HPV primary screening (ages 25-65): Every 5 years if negative — ACS 2023 guidelines support this as the preferred strategy
- Pap smear alone (ages 21-65): Every 3 years if normal — acceptable but requires more frequent visits
- After positive HPV, normal Pap: Repeat co-testing in 12 months; colposcopy if HPV persists
- After CIN2/3 treatment: Co-testing at 12 and 24 months, then annually for at least 3 years before returning to routine intervals
- High-risk groups (HIV, immunosuppression): Screening every 1-3 years depending on clinical situation
A negative HPV test provides a stronger safety guarantee than a negative Pap alone. Studies in The Lancet show that cervical cancer risk after a negative HPV test remains extremely low for at least 5 years — significantly lower than after a negative Pap alone. This evidence supports longer screening intervals with HPV-based approaches without compromising safety.
HPV Testing for Men: What Men Should Know
HPV is not exclusively a women's health issue. HPV causes a growing number of cancers in men, including oropharyngeal (throat) cancer, anal cancer, and penile cancer. HPV-related oropharyngeal cancer is now more common than cervical cancer in some developed countries.
Currently, there is no FDA-approved routine HPV screening test for men. Unlike the cervix, there is no standardized test site in males. Anal HPV testing is available for high-risk groups — men who have sex with men (MSM), those living with HIV, and men with a history of anal intraepithelial neoplasia. This is not part of routine screening for the general male population.
The most effective HPV prevention for men is vaccination. Gardasil 9 is recommended for boys and men aged 9-26, with shared clinical decision-making extending eligibility to age 45. Vaccination in males prevents genital warts, reduces anal and oropharyngeal cancer risk, and decreases HPV transmission to sexual partners. Men noticing genital warts, persistent sores, or unexplained lesions should consult a urologist promptly.
HPV Test Dubai: Insurance Coverage and Payment Options
Understanding insurance coverage for HPV testing in Dubai can save you significant out-of-pocket costs. Most comprehensive insurance plans cover HPV screening as preventive care, but coverage details vary by plan and provider.
- DHA Essential Benefits Plan: Mandates coverage for preventive screenings including cervical cancer screening
- Comprehensive plans (Daman, AXA, Bupa, MetLife, Cigna): Typically cover HPV co-testing when requested by a gynecologist as part of routine screening
- Enhanced plans: Often cover HPV vaccination as preventive care, particularly for patients under 26
- Self-pay patients: Package pricing for Pap + HPV co-test is more cost-effective than separate orders
At DCDC, direct insurance billing with 20+ insurance providers means covered patients pay nothing at the time of service — the clinic handles pre-authorization and billing directly. This eliminates the pay-and-claim process that causes delays at other facilities. DCDC's multilingual staff (Arabic, English, Farsi, Urdu, Hindi) can verify your coverage before your appointment.
HPV Myths vs Facts: Common Misconceptions
Misinformation about HPV prevents many women from getting screened. Let us address the most common myths head-on with evidence-based facts.
- Myth: Only promiscuous women get HPV. Fact: HPV is so common that approximately 80% of sexually active adults contract at least one strain. You can get HPV from a single sexual partner
- Myth: HPV positive means I have cancer. Fact: 90% of HPV infections clear spontaneously within 2 years. Only persistent infections with high-risk strains can potentially lead to cancer over 10-20 years
- Myth: I had the vaccine so I do not need screening. Fact: The vaccine covers 7 high-risk strains but not all 14. Regular screening is still recommended for vaccinated women
- Myth: Condoms fully prevent HPV. Fact: Condoms reduce HPV transmission by about 70% but do not eliminate risk because HPV spreads through skin-to-skin contact in areas condoms do not cover
- Myth: Men cannot get HPV. Fact: HPV causes cancers in men too. Vaccination is recommended for males aged 9-45
- Myth: HPV testing is only for young women. Fact: Screening is recommended for women aged 25-65. New HPV infections can occur at any age
Why Choose DCDC for HPV Testing in Dubai?
DCDC (Doctors Clinic Diagnostic Center) in Dubai Healthcare City provides comprehensive HPV testing and cervical cancer screening in a comfortable, private, and MOHAP-licensed environment. With a 4.8/5 Google rating from over 1,000 verified reviews and a 98% patient satisfaction rate, DCDC combines clinical excellence with patient-centred care.
- HPV DNA testing and Pap + HPV co-testing using advanced liquid-based cytology (ThinPrep) for maximum accuracy
- Experienced female gynecologists available for women who prefer a female doctor
- Results in 5-7 working days with gynecologist review and explanation of findings
- Gardasil 9 HPV vaccination available on-site for women and men of all eligible ages
- Colposcopy and LEEP available on-site if results require further investigation or treatment
- Direct billing with 20+ insurance providers — no pay-and-claim; coverage verified on arrival
- Same-week appointments with average wait time of 15 minutes
- Free parking at Building 64, Al Razi Medical Complex, DHCC — 10 minutes from Downtown, Business Bay, and Jumeirah
- Extended hours: Sat-Thu 8 AM-10 PM, Fri 9 AM-9 PM
For related cervical health information, see our detailed guides on cervical cancer screening and Pap smear testing in Dubai.
Related Services at DCDC
Expert care and advanced diagnostics at Dubai Healthcare City
Frequently Asked Questions
Take Control: Book Your HPV Test Today
HPV testing is one of the most powerful tools available for preventing cervical cancer. By detecting high-risk HPV infections years before they cause cell changes, the test gives you and your gynecologist the opportunity to monitor, intervene, and prevent cancer before it ever develops. Combined with HPV vaccination, screening has the potential to virtually eliminate cervical cancer — and the WHO has set a global target to achieve exactly that.
If you are overdue for cervical screening, have never been tested for HPV, or have received a positive result and need guidance on next steps, do not wait. The test takes under 10 minutes, results arrive within a week, and early detection means precancerous changes can be treated with near-100% success. At DCDC Dubai Healthcare City, our gynecology team provides comprehensive HPV testing and cervical cancer screening — Pap + HPV co-testing from AED 299, expert result interpretation, Gardasil 9 vaccination, and compassionate follow-up care. Book your screening today.
Sources & References
This article was reviewed by our medical team and references the following sources:
- World Health Organization — Human Papillomavirus (HPV) and Cervical Cancer
- American College of Obstetricians and Gynecologists (ACOG) — Cervical Cancer Screening
- American Cancer Society — HPV and HPV Testing (2023 Updated Guidelines)
- NHS — Human Papillomavirus (HPV)
- Cleveland Clinic — HPV Test: Purpose, Procedure, and Results
- Mayo Clinic — HPV Test: About This Test
- Ronco G, Dillner J, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer. The Lancet. 2014;383(9916):524-532.
Medical content on this site is reviewed by DHA-licensed physicians. See our editorial policy for more information.
Written by
Dr. Parisa Dini
OB-GYN Specialist
MD, OB-GYN
Dr. Parisa Dini is an OB-GYN Specialist at Doctors Clinic Diagnostic Center (DCDC) in Dubai Healthcare City, specializing in PCOS, menopause, and preventive women's health screening.
Related Articles
Cervical Cancer Screening Dubai: Pap Smear & HPV (2026)
Pap Smear Dubai: From AED 250, Guide & Results (2026)
Women's Health Screening Dubai: Tests by Age (2026)
Cancer Screening Dubai: Tests & Cost by Age (2026)
Breast Cancer Screening: Mammogram & BRCA Guide (2026)
More in Women's Health
HSG Test Side Effects: Pain & Recovery (2026)
Read More
Mammogram Cost Dubai: AED 250–900 (2026)
Read More
NIPT Test Dubai: Cost, Accuracy & Timing (2026)
Read More
Pregnancy Blood Test Dubai: Cost & Guide (2026)
Read More
AMH Test Cost Dubai: Pricing Guide (2026)
Read More
Perimenopause vs Menopause Dubai: Signs (2026)
Read More© 2026 Doctors Clinic Diagnostic Center (DCDC), Dubai Healthcare City. Originally published at https://doctorsclinicdubai.ae/blog/hpv-test-dubai-guide. All rights reserved. Unauthorized reproduction is prohibited.